Nutex Health — Third Quarter 2026 Earnings Summary

Nutex Health reported net income of $152.9 million for the nine months ended September 30, 2026, a 159% increase from the same period in 2025, driven largely by a significant reduction in stock-based compensation and a $52.3 million non-cash adjustment to contract services expenses. Total revenue for the nine-month period decreased 10.9% to $644.9 million, primarily due to favorable revenue recognition factors in the prior year, while hospital division visits increased 10.2% year over year to 154,326. The company's balance sheet strengthened with cash and cash equivalents rising to $249.9 million and long-term debt increasing slightly to $34.2 million as of September 30, 2026.